4Schellekens GA, Visser H, de Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide[J]. Arthritis Rheum, 2000,43 (1) : 155-163.
6Schellekens GA, de Jong BA, van den Hoogen FH, et al.Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies[J]. JClin Invest, 1998,101(1):273-281.
二级参考文献20
1Skriner K, Sommergraber WH, Tremmel V, et al.Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogenous nuclear Riobonueleoprotein Complex[J]. J Clin Invest,1997,100 : 127-135.
2Kurki P, Aho K, Palosuo T, et al. Immunopathology of rheumatoid disease: antikeratin antibody precede the clinical disease [ J ]. Arthritis Rheum, 1992, 35 : 914-917.
3Visser H. How to diagnose rheumatoid arthritis early: a prediction model for persistent erosive arthritis. Arthritis Rheum, 2002, 46:357-365.
4Schellekens GA, Visser H, de Jong BAW, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic cirtrullinated peptide. Arthritis Rheum, 2000, 43: 155-163.
5Sharp JT, Young DY, Bluhm GB, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis. Arthritis Rheum,1985, 28: 1326-1335.
6Kroot EJJA, de Jong BAW, van Leeuwen MA, et al. The prognostic value of anti- cyclic cirtrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum, 2000,43: 1831-1835.
7Bas S, Perneger TY. Diagnostic tests for rheumatoid arthritis:comparison of anti-cyclic cirtrullinated peptide antibodies, antikeratin antibodies and IgM rheumatoid factors. Rheumatology,2002, 41: 809-814.
